Aerobic exercise during early murine doxorubicin exposure mitigates cardiac toxicity

Fei Wang, Brian Iskra, Eugenie Kleinerman, Claudia Alvarez-Florez, Thomas Andrews, Angela Shaw, Joya Chandra, Keri Schadler, Gregory J. Aune

Research output: Contribution to journalArticle

  • 2 Citations

Abstract

We report the cardioprotective effects of moderate aerobic exercise from parallel pediatric murine models of doxorubicin (Doxo) exposure in non-tumor-bearing immune competent (NTB-IC) mice and tumor-bearing nude mice (TB-NM). In both models, animals at 4 weeks of age underwent Doxo treatment with or without 2 weeks of simultaneous exercise. In sedentary NTB-IC or TB-NM mice, Doxo treatment resulted in a statistically significant decrease in ejection fraction and fractional shortening compared with control animals. Interestingly, moderate aerobic exercise during Doxo treatment significantly mitigated decreases in ejection fraction and fractional shortening. In contrast, these protective effects of exercise were not observed when exercise was started after completion of Doxo treatments. Moreover, in the TB-NM model, Doxo caused a decrease in heart mass: tibia length and in body weight that was prevented by exercise, whereas NTB-IC mice exhibited no change in these measurements. Doxo delivery to the hearts of TB-NM was decreased by consistent moderate aerobic exercise before Doxo injection. These findings demonstrate the important but subtle differences in cardiotoxicity observed in different mouse models. Collectively, these results also strongly suggest that aerobic exercise during early-life Doxo exposure mitigates cardiotoxicity, possibly through altered delivery of Doxo to myocardial tissue.

LanguageEnglish (US)
Pages208-215
Number of pages8
JournalJournal of Pediatric Hematology/Oncology
Volume40
Issue number3
DOIs
StatePublished - Jan 1 2018

Fingerprint

Doxorubicin
Exercise
Nude Mice
Cardiotoxicity
Neoplasms
Heart Neoplasms
Therapeutics
Tibia
Animal Models
Body Weight
Pediatrics
Injections

Keywords

  • Aerobic exercise
  • cardiotoxicity
  • doxorubicin

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Aerobic exercise during early murine doxorubicin exposure mitigates cardiac toxicity. / Wang, Fei; Iskra, Brian; Kleinerman, Eugenie; Alvarez-Florez, Claudia; Andrews, Thomas; Shaw, Angela; Chandra, Joya; Schadler, Keri; Aune, Gregory J.

In: Journal of Pediatric Hematology/Oncology, Vol. 40, No. 3, 01.01.2018, p. 208-215.

Research output: Contribution to journalArticle

Wang, F, Iskra, B, Kleinerman, E, Alvarez-Florez, C, Andrews, T, Shaw, A, Chandra, J, Schadler, K & Aune, GJ 2018, 'Aerobic exercise during early murine doxorubicin exposure mitigates cardiac toxicity' Journal of Pediatric Hematology/Oncology, vol. 40, no. 3, pp. 208-215. https://doi.org/10.1097/MPH.0000000000001112
Wang, Fei ; Iskra, Brian ; Kleinerman, Eugenie ; Alvarez-Florez, Claudia ; Andrews, Thomas ; Shaw, Angela ; Chandra, Joya ; Schadler, Keri ; Aune, Gregory J. / Aerobic exercise during early murine doxorubicin exposure mitigates cardiac toxicity. In: Journal of Pediatric Hematology/Oncology. 2018 ; Vol. 40, No. 3. pp. 208-215.
@article{1a5c6607ba814831bbd82db29943627c,
title = "Aerobic exercise during early murine doxorubicin exposure mitigates cardiac toxicity",
abstract = "We report the cardioprotective effects of moderate aerobic exercise from parallel pediatric murine models of doxorubicin (Doxo) exposure in non-tumor-bearing immune competent (NTB-IC) mice and tumor-bearing nude mice (TB-NM). In both models, animals at 4 weeks of age underwent Doxo treatment with or without 2 weeks of simultaneous exercise. In sedentary NTB-IC or TB-NM mice, Doxo treatment resulted in a statistically significant decrease in ejection fraction and fractional shortening compared with control animals. Interestingly, moderate aerobic exercise during Doxo treatment significantly mitigated decreases in ejection fraction and fractional shortening. In contrast, these protective effects of exercise were not observed when exercise was started after completion of Doxo treatments. Moreover, in the TB-NM model, Doxo caused a decrease in heart mass: tibia length and in body weight that was prevented by exercise, whereas NTB-IC mice exhibited no change in these measurements. Doxo delivery to the hearts of TB-NM was decreased by consistent moderate aerobic exercise before Doxo injection. These findings demonstrate the important but subtle differences in cardiotoxicity observed in different mouse models. Collectively, these results also strongly suggest that aerobic exercise during early-life Doxo exposure mitigates cardiotoxicity, possibly through altered delivery of Doxo to myocardial tissue.",
keywords = "Aerobic exercise, cardiotoxicity, doxorubicin",
author = "Fei Wang and Brian Iskra and Eugenie Kleinerman and Claudia Alvarez-Florez and Thomas Andrews and Angela Shaw and Joya Chandra and Keri Schadler and Aune, {Gregory J.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/MPH.0000000000001112",
language = "English (US)",
volume = "40",
pages = "208--215",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Aerobic exercise during early murine doxorubicin exposure mitigates cardiac toxicity

AU - Wang, Fei

AU - Iskra, Brian

AU - Kleinerman, Eugenie

AU - Alvarez-Florez, Claudia

AU - Andrews, Thomas

AU - Shaw, Angela

AU - Chandra, Joya

AU - Schadler, Keri

AU - Aune, Gregory J.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - We report the cardioprotective effects of moderate aerobic exercise from parallel pediatric murine models of doxorubicin (Doxo) exposure in non-tumor-bearing immune competent (NTB-IC) mice and tumor-bearing nude mice (TB-NM). In both models, animals at 4 weeks of age underwent Doxo treatment with or without 2 weeks of simultaneous exercise. In sedentary NTB-IC or TB-NM mice, Doxo treatment resulted in a statistically significant decrease in ejection fraction and fractional shortening compared with control animals. Interestingly, moderate aerobic exercise during Doxo treatment significantly mitigated decreases in ejection fraction and fractional shortening. In contrast, these protective effects of exercise were not observed when exercise was started after completion of Doxo treatments. Moreover, in the TB-NM model, Doxo caused a decrease in heart mass: tibia length and in body weight that was prevented by exercise, whereas NTB-IC mice exhibited no change in these measurements. Doxo delivery to the hearts of TB-NM was decreased by consistent moderate aerobic exercise before Doxo injection. These findings demonstrate the important but subtle differences in cardiotoxicity observed in different mouse models. Collectively, these results also strongly suggest that aerobic exercise during early-life Doxo exposure mitigates cardiotoxicity, possibly through altered delivery of Doxo to myocardial tissue.

AB - We report the cardioprotective effects of moderate aerobic exercise from parallel pediatric murine models of doxorubicin (Doxo) exposure in non-tumor-bearing immune competent (NTB-IC) mice and tumor-bearing nude mice (TB-NM). In both models, animals at 4 weeks of age underwent Doxo treatment with or without 2 weeks of simultaneous exercise. In sedentary NTB-IC or TB-NM mice, Doxo treatment resulted in a statistically significant decrease in ejection fraction and fractional shortening compared with control animals. Interestingly, moderate aerobic exercise during Doxo treatment significantly mitigated decreases in ejection fraction and fractional shortening. In contrast, these protective effects of exercise were not observed when exercise was started after completion of Doxo treatments. Moreover, in the TB-NM model, Doxo caused a decrease in heart mass: tibia length and in body weight that was prevented by exercise, whereas NTB-IC mice exhibited no change in these measurements. Doxo delivery to the hearts of TB-NM was decreased by consistent moderate aerobic exercise before Doxo injection. These findings demonstrate the important but subtle differences in cardiotoxicity observed in different mouse models. Collectively, these results also strongly suggest that aerobic exercise during early-life Doxo exposure mitigates cardiotoxicity, possibly through altered delivery of Doxo to myocardial tissue.

KW - Aerobic exercise

KW - cardiotoxicity

KW - doxorubicin

UR - http://www.scopus.com/inward/record.url?scp=85044765039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044765039&partnerID=8YFLogxK

U2 - 10.1097/MPH.0000000000001112

DO - 10.1097/MPH.0000000000001112

M3 - Article

VL - 40

SP - 208

EP - 215

JO - Journal of Pediatric Hematology/Oncology

T2 - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 3

ER -